ÇÕ¼º»ý¹°ÇÐ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Á¦Ç°º°, ±â¼úº°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)
Synthetic Biology Market Size, Share & Trends Analysis Report By Product (Enzymes, Cloning Technologies Kits), By Technology (PCR, NGS), By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030
»óǰÄÚµå : 1587834
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2024³â 10¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 150 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,609,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 10,055,000
Printable PDF (5-User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,949,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ÇÕ¼º»ý¹°ÇÐ ½ÃÀå ¼ºÀå°ú µ¿Çâ:

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¼¼°è ÇÕ¼º»ý¹°ÇÐ ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 420¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 17.30%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¹é½Å ¿¬±¸¸¦ Áö¿øÇÏ´Â Á¤ºÎ ¹× ¹Î°£ ÀÚ±ÝÀÇ Á¸Àç¿Í ÀÓ»ó½ÃÇè ÁßÀÎ °­·ÂÇÑ ÇÕ¼º»ý¹°ÇÐÀû ±â¹Ý Á¦Ç° ÆÄÀÌÇÁ¶óÀÎÀÌ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀÔ´Ï´Ù. ÇÕ¼º»ý¹°ÇÐÀû °øÁ¤Àº Áúº´ ½Äº°À» À§ÇÑ Ç׿ø ¹× Áø´Ü ½Ã¾à »ý»ê, ¹é½Å °³¹ß ¼Óµµ Çâ»ó, Àü¹ÝÀûÀÎ ¹é½Å ¼º´É ¹× ¼öÀ² Çâ»ó¿¡ °áÁ¤ÀûÀÎ ÀÌÁ¡À» Á¦°øÇÕ´Ï´Ù.

¶ÇÇÑ, Á¤ºÎ ±â°üÀÇ Áö¿ø°ú ¿©·¯ ÇÁ·Î±×·¥ÀÇ Á¸Àç´Â ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹¿¡¼­´Â COVID-19 ¹é½ÅÀÇ ¿¬±¸ °³¹ß, Á¦Á¶, ±ÔÁ¦ ¹× ±¸¸Å°¡ Biomedical Advanced Research and Development Authority(BARDA), National Institutes of Health(NIH), DOD, FDA, ±âŸ(±¸ OWS)¸¦ Æ÷ÇÔÇÑ ¿¬¹æ Á¤ºÎ ±â°üÀÇ Çù·ÂÀ¸·Î ³ôÀº ¼öÁØÀÇ Áö¿øÀ» ¹Þ°í ÀÖ½À´Ï´Ù.

¼¶À¯ ¹× ¿µ¾ç°ú °°Àº »ê¾÷ÀÇ ¼ö¿ä Áõ°¡¿Í °°Àº ´Ù¸¥ ¿äÀε鵵 ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÇÕ¼º»ý¹°ÇÐÀÇ µµ¿òÀ¸·Î ¸î °¡Áö ÃÖÀûÀÇ ½Äǰ »ý»ê °øÁ¤ÀÌ È®ÀεǾú½À´Ï´Ù. ¶ÇÇÑ, ÇÕ¼º»ý¹°ÇÐÀº ´õ ³ôÀº ³ó¾÷ ¼öÈ®·® âÃâ°ú ÇØÃæ ¹æÁ¦ °³¹ß¿¡ µµ¿òÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´õ ³ªÀº ½Ä·® ¼öÈ®·® »ý»ê°ú ÇØÃæ ¹æÁ¦ °ü¸®¿¡ µµ¿òÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

COVID-19 ÆÒµ¥¹ÍÀº ½ÃÀå ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÇÕ¼º»ý¹°ÇÐÀº ¹Ì±¹ ±¹¸³º¸°Ç¿ø(NIH)ÀÌ ¹é½Å °³¹ßÀ» °¡¼ÓÈ­ÇÒ ¼ö ÀÖ´Â ¼ö´ÜÀ¸·Î °¢±¤¹Þ°í ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ÇÕ¼º»ý¹°ÇÐ ¿¬±¸¼Ò¿Í ±â¾÷µéÀº COVID-19 ÆÒµ¥¹Í¿¡ ´ëÀÀÇϱâ À§ÇØ ÇÕ¼º»ý¹°ÇÐ ±â¼úÀ» Àû±ØÀûÀ¸·Î Ȱ¿ëÇϰí ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ÆÒµ¥¹Í ±â°£ µ¿¾È ÀÌ·¯ÇÑ ±â¼úÀÇ È°¿ëÀÌ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ÇâÈÄ ¸î ³â µ¿¾È ½ÃÀå ¼ºÀåÀÇ Å« ¿øµ¿·ÂÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Ä¡·áÁ¦·Î »ç¿ëÇϵµ·Ï ¼³°èµÈ »õ·Î¿î ´Ü¹éÁúÀÇ »ç¿ëÀº ÀÇ·á ºÐ¾ß¿¡¼­ ÇÕ¼º»ý¹°ÇÐÀ» ÀÔÁõÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ´Ü¹éÁúÀº Ä¡·á¿¡ ÇÊ¿äÇÑ ¹Ù¶÷Á÷ÇÑ Æ¯¼ºÀ» ¾ò±â À§ÇØ ´Ü¹éÁúÀÇ ±¸Á¶¸¦ ÀϺΠº¯°æÇÏ¿© ¼³°èµÇ¾ú½À´Ï´Ù. ¿¹¸¦ µé¾î, ¿¬±¸ÀÚµéÀº Æä´ÒÄÉÅæ´¢Áõ(PKU)À» Ä¡·áÇϱâ À§ÇØ ¼ÒÈ­°ü¿¡ ¾ÈÁ¤ÀûÀÌ°í °æ±¸ Åõ¿©°¡ °¡´ÉÇÑ Ä¡·á¿ë È¿¼Ò È常¦ °³¹ßÇϰí ÀÖ½À´Ï´Ù.

¹Ý¸é, ÇÕ¼º»ý¹°ÇÐÀº ¹ÙÀÌ¿À º¸¾È ¹× »ý¹° ¾ÈÀü°ú °ü·ÃÇÏ¿© ¸î °¡Áö ¿ì·Á¸¦ ºÒ·¯ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¦Ç°¿¡ ³ëÃâµÉ °æ¿ì °øÁߺ¸°Ç°ú ȯ°æ¿¡ ¾Ë·ÁÁöÁö ¾ÊÀº À§ÇèÀÌ ¹ß»ýÇÒ ¼ö Àֱ⠶§¹®ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ¹®Á¦¸¦ ¹æÁöÇϱâ À§ÇØ À¯·´, ºÏ¹Ì, ³²¹Ì, ¾Æ½Ã¾Æ °¢±¹Àº ±âÃÊ ¹× ÀÀ¿ë ¿¬±¸¿¡¼­ÀÇ ÇÕ¼º»ý¹°ÇÐ ±â¼ú Àû¿ëÀ» °ü¸®Çϱâ À§ÇÑ Á¤Ã¥À» ¼ö¸³Çϰí ÀÖ½À´Ï´Ù.

ÇÕ¼º»ý¹°ÇÐ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå Á¦Ç° ºñÁî´Ï½º ºÐ¼®

Á¦5Àå ±â¼ú ºñÁî´Ï½º ºÐ¼®

Á¦6Àå ¿ëµµ ºñÁî´Ï½º ºÐ¼®

Á¦7Àå ÃÖÁ¾ ¿ëµµ ºñÁî´Ï½º ºÐ¼®

Á¦8Àå Áö¿ª ºñÁî´Ï½º ºÐ¼®

Á¦9Àå °æÀï »óȲ

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Synthetic Biology Market Growth & Trends:

The global synthetic biology market size is expected to reach USD 42.06 billion by 2030, registering a CAGR of 17.30% 2025 to 2030, according to a new report by Grand View Research, Inc. The presence of government and private funding to support research in vaccines and a strong synthetic biologic-based product pipeline in clinical trials are the key driving factors for the market. Synthetic biology processes provide crucial advantages for producing antigen and diagnostic reagents for disease identification, accelerating the speed of vaccine development, and improving overall vaccine performance and yield.

Furthermore, support from government agencies and the presence of several programs are likely to boost the market growth. For instance, in the U.S., COVID-19 vaccine R&D, manufacture, regulation, and purchase have been highly supported by collaboration between federal agencies, including the Biomedical Advanced Research and Development Authority (BARDA), the National Institutes of Health (NIH), DOD, FDA, and others (formerly OWS).

Other factors such as expanding demand in industries such as textiles and nutrition are also contributing to the market growth. Several optimal food production processes have been identified with the help of synthetic biology. In addition, synthetic biology is predicted to aid in the generation of higher agricultural yields and pest control development. It is expected to help in the production of better food yield and pest control management.

The COVID-19 pandemic is anticipated to positively impact market growth. Synthetic biology has been highlighted as a means to accelerate vaccine development by the National Institute of Health in the U.S. Therefore, synthetic biology labs and companies have been actively utilizing this technology to combat the COVID-19 pandemic. As a result, the usage of these technologies is projected to increase during the outbreak.

The growing demand for personalized medicine is expected to majorly drive market growth during the coming years. The use of engineered novel proteins for use as therapeutics has demonstrated synthetic biology in the medical segment. These proteins are designed with some modified protein structure to get the desirable properties required for the treatment. For instance, researchers are developing a therapeutic enzyme candidate that is GI-stable and can be given via oral route to treat Phenylketonuria (PKU).

On the other hand, synthetic biology has raised a few concerns regarding biosecurity and biosafety. Exposure to these products may cause unknown hazards to public health and the environment. To prevent such issues, countries of Europe, the Americas, and Asia have formulated policies to manage the application of synthetic biology techniques in basic & applied research.

Synthetic Biology Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Market Variables, Trends, & Scope

Chapter 4. Product Business Analysis

Chapter 5. Technology Business Analysis

Chapter 6. Application Business Analysis

Chapter 7. End Use Business Analysis

Chapter 8. Regional Business Analysis

Chapter 9. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â